Guardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEO

Stock Information for Guardion Health Sciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Guardion Health Sciences Inc.

Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor's Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution
Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business
Guardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company's Special Meeting of Stockholders to be held on May 23, 2024
Guardion Health Sciences Announces
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor's Best Inc.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.